1. Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men. (21st October 2020) Authors: Goren, A.; Wambier, C.G.; Herrera, S.; McCoy, J.; Vaño‐Galván, S.; Gioia, F.; Comeche, B.; Ron, R.; Serrano‐Villar, S.; Ramos, P.M.; Cadegiani, F.A.; Kovacevic, M.; Tosti, A.; Shapiro, J.; Sinclair, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 1(2021) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19. (8th November 2020) Authors: Cadegiani, F.A.; Lim, R.K.; Goren, A.; McCoy, J.; Situm, M.; Kovacevic, M.; Vañó Galván, S.; Sinclair, R.; Tosti, A.; Wambier, C.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis. (July 2017) Authors: Lekic, A.; Brekalo, Z.; Kvesic, A.; Kovacevic, M.; Baricev‐Novakovic, Z.; Sutic, I.; Bulog, A.; Sutic, I.; Pavisic, V.; Mrakovcic‐Sutic, I. Journal: Scandinavian journal of immunology Issue: Volume 86:Number 1(2017:Jul.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low‐dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Issue 6 (8th October 2018) Authors: Goren, A.; Sharma, A.; Dhurat, R.; Shapiro, J.; Sinclair, R.; Situm, M.; Kovacevic, M.; Lukinovic Skudar, V.; Goldust, M.; Lotti, T.; McCoy, J. Journal: Dermatologic therapy Issue: Volume 31:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0898: Identification of individual NTCP benefit of dose-escalated IMPT in advanced HNC patients. (April 2015) Authors: Jakobi, A.; Bandurska-Luque, A.; Stützer, K.; Haase, R.; Löck, S.; Wack, L.; Mönnich, D.; Thorwarth, D.; Kovacevic, M.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0946: Prospective evaluation of patient positioning for interfractional variation in proton therapy of prostate cancer. (April 2015) Authors: Schneidt, M.; Kovacevic, M.; Thiele, J.; Jakobi, A.; Haase, R.; Makocki, S.; Krause, M.; Hölscher, T.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗